Hedge Fund - Cormorant Asset Management
Moonlake Immunotherapeutics (MLTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $57,404,607 | 2.65% | 4,355,433 | $ |
| 2 | 2025 - Q3 (2025-09-30) | $14,298,220 | 0.99% | 1,994,173 | $ |
| 3 | 2025 - Q2 (2025-06-30) | $400,923,927 | 29.86% | 8,494,151 | $ |
| 4 | 2025 - Q1 (2025-03-31) | $331,866,480 | 24.95% | 8,494,151 | $ |
| 5 | 2024 - Q4 (2024-12-31) | $459,958,277 | 25.26% | 8,494,151 | $ |
| 6 | 2024 - Q3 (2024-09-30) | $428,275,093 | 22.71% | 8,494,151 | $ |
| 7 | 2024 - Q2 (2024-06-30) | $373,487,819 | 21.57% | 8,494,151 | $ |
| 8 | 2024 - Q1 (2024-03-31) | $426,661,205 | 18.71% | 8,494,151 | $ |
| 9 | 2023 - Q4 (2023-12-31) | $512,961,779 | 24.49% | 8,494,151 | $ |
| 10 | 2023 - Q3 (2023-09-30) | $464,099,700 | 27.07% | 8,142,100 | $ |
| 11 | 2023 - Q2 (2023-06-30) | $415,247,100 | 23.26% | 8,142,100 | $ |
| 12 | 2023 - Q1 (2023-03-31) | $147,422 | 9.7% | 6,892,101 | $ |
| 13 | 2022 - Q4 (2022-12-31) | $63,683 | 4.26% | 6,065,001 | $ |
| 14 | 2022 - Q3 (2022-09-30) | $47,064,000 | 3.28% | 6,065,001 | $ |
| 15 | 2022 - Q2 (2022-06-30) | $30,886,000 | 2.33% | 6,065,001 | $ |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center